Fritsche HM - Search Results

1

The plasmacytoid carcinoma of the bladder--rare variant of aggressive urothelial carcinoma.

Keck B, Stoehr R, Wach S, Rogler A, Hofstaedter F, Lehmann J, Montironi R, Sibonye M, Fritsche HM, Lopez-Beltran A, Epstein JI, Wullich B, Hartmann A. Keck B, et al. Among authors: fritsche hm. Int J Cancer. 2011 Jul 15;129(2):346-54. doi: 10.1002/ijc.25700. Epub 2010 Dec 1. Int J Cancer. 2011. PMID: 20878954

2

Prognostic value of histopathological tumour growth patterns at the invasion front of T1G3 urothelial carcinoma of the bladder.

Denzinger S, Burger M, Fritsche HM, Bertz S, Hofstädter F, Wieland WF, Hartmann A, Otto W. Denzinger S, et al. Among authors: fritsche hm. Scand J Urol Nephrol. 2009;43(4):282-7. doi: 10.1080/00365590902854354. Scand J Urol Nephrol. 2009. PMID: 19382004

3

The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer.

Otto W, Denzinger S, Fritsche HM, Burger M, Wieland WF, Hofstädter F, Hartmann A, Bertz S. Otto W, et al. Among authors: fritsche hm. BJU Int. 2011 Feb;107(3):404-8. doi: 10.1111/j.1464-410X.2010.09515.x. Epub 2010 Aug 12. BJU Int. 2011. PMID: 20707791 Review.

4

Risk stratification for locoregional recurrence after radical cystectomy for urothelial carcinoma of the bladder.

Novotny V, Froehner M, May M, Protzel C, Hergenröther K, Rink M, Chun FK, Fisch M, Roghmann F, Palisaar RJ, Noldus J, Gierth M, Fritsche HM, Burger M, Sikic D, Keck B, Wullich B, Nuhn P, Buchner A, Stief CG, Vallo S, Bartsch G, Haferkamp A, Bastian PJ, Hakenberg OW, Propping S, Aziz A. Novotny V, et al. Among authors: fritsche hm. World J Urol. 2015 Nov;33(11):1753-61. doi: 10.1007/s00345-015-1502-y. Epub 2015 Feb 8. World J Urol. 2015. PMID: 25663359

5

Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta.

Aziz A, Gierth M, Rink M, Schmid M, Chun FK, Dahlem R, Roghmann F, Palisaar RJ, Noldus J, Ellinger J, Müller SC, Pycha A, Martini T, Bolenz C, Moritz R, Herrmann E, Keck B, Wullich B, Mayr R, Fritsche HM, Burger M, Bastian PJ, Seitz C, Brookman-May S, Xylinas E, Shariat SF, Fisch M, May M; PROMETRICS 2011 Research Group. Aziz A, et al. Among authors: fritsche hm. World J Urol. 2015 Dec;33(12):1945-50. doi: 10.1007/s00345-015-1572-x. Epub 2015 May 7. World J Urol. 2015. PMID: 25947885

6

Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patients.

Denzinger S, Otto W, Fritsche HM, Roessler W, Wieland WF, Hartmann A, Burger M. Denzinger S, et al. Among authors: fritsche hm. Int J Urol. 2007 Nov;14(11):995-9; discussion 999. doi: 10.1111/j.1442-2042.2007.01890.x. Int J Urol. 2007. PMID: 17956523

7

Serine threonine kinase 15 amplification in normal urothelium of cystectomy specimens is no prognostic factor in urothelial carcinoma of the bladder.

Otto W, Fritsche HM, Wild PJ, Wieland WF, Hartmann A, Burger M, Hofstädter F, Denzinger S. Otto W, et al. Among authors: fritsche hm. Pathol Res Pract. 2011 Mar 15;207(3):161-3. doi: 10.1016/j.prp.2010.12.006. Epub 2011 Jan 17. Pathol Res Pract. 2011. PMID: 21247708

8

Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer.

Otto W, Rubenwolf PC, Burger M, Fritsche HM, Rößler W, May M, Hartmann A, Hofstädter F, Wieland WF, Denzinger S. Otto W, et al. Among authors: fritsche hm. BMC Cancer. 2012 Oct 8;12:459. doi: 10.1186/1471-2407-12-459. BMC Cancer. 2012. PMID: 23043286 Free PMC article.

9

Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundred six patients.

Otto W, Denzinger S, Fritsche HM, Burger M, Rößler W, Bertz S, May M, Hartmann A, Hofstädter F, Wieland WF, Eder F. Otto W, et al. Among authors: fritsche hm. Clin Genitourin Cancer. 2013 Dec;11(4):537-44. doi: 10.1016/j.clgc.2013.05.001. Epub 2013 Jul 10. Clin Genitourin Cancer. 2013. PMID: 23850551

10

Effect of Hospital and Surgeon Case Volume on Perioperative Quality of Care and Short-term Outcomes After Radical Cystectomy for Muscle-invasive Bladder Cancer: Results From a European Tertiary Care Center Cohort.

Vetterlein MW, Meyer CP, Leyh-Bannurah SR, Mayr R, Gierth M, Fritsche HM, Burger M, Keck B, Wullich B, Martini T, Bolenz C, Pycha A, Hanske J, Roghmann F, Noldus J, Bastian PJ, Gilfrich C, May M, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A; PROMETRICS 2011 study group. Vetterlein MW, et al. Among authors: fritsche hm. Clin Genitourin Cancer. 2017 Oct;15(5):e809-e817. doi: 10.1016/j.clgc.2017.04.021. Epub 2017 Apr 26. Clin Genitourin Cancer. 2017. PMID: 28550955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

204 results

Search Page